Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.21 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] Acceptance for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.2 above on the basis of clause (ba) of Section 1.21 but is the same Class as 1.15 and from the Class of [**] ]Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.15 [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.5 and Milestone Event B.1 above on the basis of clause (b) of Section 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.5 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.21 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]Target
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 111. First [**] filing with the [**] for a subsequent Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event B.1 D.7 above on the basis of clause (b) of Section 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.5 above on the basis of clause (b) of Section 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 A.5 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 111. First [**] filing with the [**] for a subsequent Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event B.1 D.7 above on the basis of clause (b) of Section 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] Acceptance for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] ]Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.2 above on the basis of clause (ba) of Section 1.21 but is the same Class as and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.21 [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 17. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 D.3 above on the basis of clause (b) of Section 1.21 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 13. First [**] filing with the [**] for a Class of each [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (ba) of Section 1.21 but is the same Class as and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.21 [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 111. First [**] filing with the [**] for a subsequent Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 and Milestone Event B.1 D.7 above on the basis of clause (b) of Section 1.21 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] ]Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.21 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 17. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 D.3 above on the basis of clause (b) of Section 1.21 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] Acceptance for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.2 above on the basis of clause (ba) of Section 1.21 but is the same Class as 1.15 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.15 [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] Acceptance for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 A.2 above on the basis of clause (ba) of Section 1.21 but is the same Class as and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.21 [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 17. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 D.3 above on the basis of clause (b) of Section 1.21 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 D.3 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 1. First [**] filing with the [**] for a Class of [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (b) of Section 1.21 1.15 but is the same Class as the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 above on the basis of Gene Target [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)
Milestone Event Milestone Payment. 15. First [**] filing with from the [**] for a Class of for each [**] Engineered T-Cell Product that differs from the Class of [**] Engineered T-Cell Product that was the subject of Milestone Event A.4 and Milestone Event B.1 above on the basis of clause (ba) of Section 1.21 but is the same Class as 1.15 and from the Class of [**] Engineered T-Cell Product that was the subject of a prior achievement of this Milestone Event A.4 above on the basis of Gene Target clause (a) of Section 1.15 [**]
Appears in 1 contract
Samples: Collaboration and License Agreement (Editas Medicine, Inc.)